Marla Dubinsky, MD, from Icahn School of Medicine at Mount Sinai Hospital, discusses fertility among women with IBD, why managing these patients may not be as simple as it seems, and more.
At the 2019 IAS Meeting, David T. Rubin, MD, highlighted current challenges in IBD management, the importance of proactive care, and treat to target strategies.
Stephen Hanauer, MD, from Northwestern Medicine, highlights breakthroughs in autoimmune diseases, the upcoming Interdisciplinary Autoimmune Summit (IAS), and more.
In this commentary, Dr Miguel Regueiro from Cleveland Clinic highlights potential adverse effects of biologics that should be considered when selecting the ideal treatment for a patient with inflammatory...
Dr Stephen Hanauer from Northwestern Medicine discusses the roles of TNF inhibitors and immunomodulators in managing IBD, how gastroenterologists can position the use of each therapeutic, and more.
Dr Mark Deneau from University of Utah Health discusses the current management of pediatric inflammatory bowel disease and primary sclerosing cholangitis, the importance of identifying patients for...
Dr Sunanda Kane, president of the American College of Gastroenterology, discusses current guidelines for managing severe ulcerative colitis, controversies surrounding rescue treatment, and more.
A 6-minute withdrawal time during screening and surveillance colonoscopy—the standard of care—has been known to improve adenoma detection rate (ADR), a quality measure for...
Kalpit Devani, MD, from East Tennessee State University answers our questions about his study presented at the ACG 2018 about early colonoscopy in acute lower gastrointestinal bleeding.
